Original Research
Published on 23 Feb 2024
Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma
in Gastrointestinal and Hepatic Pharmacology
- 2,054 views